Pluri Inc. (NASDAQ:PLUR) Sees Large Growth in Short Interest

Pluri Inc. (NASDAQ:PLUR) was the target of a significant increase in short interest during the month of January. As of January 15th, there was short interest totaling 18,051 shares, an increase of 24.1% from the December 31st total of 14,548 shares. Based on an average daily trading volume, of 7,742 shares, the short-interest ratio is currently 2.3 days. Currently, 0.2% of the shares of the company are sold short. Currently, 0.2% of the shares of the company are sold short. Based on an average daily trading volume, of 7,742 shares, the short-interest ratio is currently 2.3 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Pluri in a research note on Thursday, January 22nd. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $12.00.

Pluri Stock Down 2.3%

Shares of NASDAQ PLUR traded down $0.08 during midday trading on Wednesday, reaching $3.41. 820 shares of the stock were exchanged, compared to its average volume of 9,662. The firm has a market cap of $34.04 million, a price-to-earnings ratio of -0.72 and a beta of 0.67. The firm has a 50-day simple moving average of $3.23 and a two-hundred day simple moving average of $4.08. Pluri has a twelve month low of $2.82 and a twelve month high of $7.13.

Pluri (NASDAQ:PLUR) last announced its quarterly earnings results on Wednesday, November 12th. The company reported ($0.65) earnings per share (EPS) for the quarter. The company had revenue of $0.32 million for the quarter.

Hedge Funds Weigh In On Pluri

An institutional investor recently bought a new position in Pluri stock. Jane Street Group LLC purchased a new stake in Pluri Inc. (NASDAQ:PLUR) during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 10,928 shares of the company’s stock, valued at approximately $47,000. Jane Street Group LLC owned 0.14% of Pluri as of its most recent filing with the SEC. 16.59% of the stock is owned by hedge funds and other institutional investors.

About Pluri

Pluri (NASDAQ:PLUR) is a clinical-stage biotechnology company focused on the development and manufacturing of placental-derived cell therapy products. The company’s proprietary three-dimensional microcarrier expansion platform enables large-scale, off-the-shelf production of PLX (placental expanded) cells, which are being investigated for a range of acute and chronic conditions. Pluri’s approach seeks to combine the regenerative and immunomodulatory properties of stromal cells with a scalable manufacturing process that does not require patient-specific cell harvesting.

Pluri advances its pipeline through internally funded research programs and strategic collaborations with academic institutions and government agencies.